Stay updated on Nivolumab Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ibrutinib in CLL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:21:02.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Study status updated to Completed; results have been posted and enrollment and completion dates updated.
    Difference
    0.0%
    Check dated 2026-03-04T23:42:54.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The change is a minor version update (v3.4.2 replacing v3.4.1) and does not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-11T11:32:20.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new page revision, v3.4.1, was added and the previous revision v3.4.0 was removed; this appears to be a backend/UI version update rather than a change to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T07:41:05.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and site revision information (v3.4.0) along with the updated 'Last Update Submitted that Met QC Criteria' label. The previous wording 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision 'v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T05:41:15.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 on the page. There are no visible changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:20:32.000Z thumbnail image

Stay in the know with updates to Nivolumab Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.